Ginsenoside Rg1 helps mice resist to disseminated candidiasis by Th1 type differentiation of CD4+ T cell
- 1 September 2006
- journal article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 6 (9), 1424-1430
- https://doi.org/10.1016/j.intimp.2006.04.009
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Toll-like receptors and innate antifungal responsesTrends in Microbiology, 2004
- Immunomodulatory Effects of Anti-CD4 Antibody in Host Resistance against Infections and Tumors in Human CD4 Transgenic MiceInfection and Immunity, 2001
- Protection against Candidiasis by an Immunoglobulin G3 (IgG3) Monoclonal Antibody Specific for the Same Mannotriose as an IgM Protective AntibodyInfection and Immunity, 2000
- Effects of ginsenosides on impaired performance induced in the rat by scopolamine in a radial-arm mazePsychoneuroendocrinology, 1995
- A TH1-TH2-like switch in candidiasis: new perspectives for therapyTrends in Microbiology, 1995
- Interleukin‐4 and ‐10 exacerbate candidiasis in miceEuropean Journal of Immunology, 1995
- Invasive Candida InfectionsNew England Journal of Medicine, 1991
- Effects of Ginsenoside Rbi on Central Cholinergic MetabolismPharmacology, 1991
- The emergence of fungi as major hospital pathogensJournal of Hospital Infection, 1988
- Ginseng Saponins: Influence on Neurotransmitter Uptake in Rat Brain SynaptosomesPlanta Medica, 1985